The positive outcome of using GnRH agonist pretreatment before ART in women with adenomyosis was demonstrated by two retrospective controlled studies, which compared GnRH agonist pretreatment and no treatment before fresh embryo transfer [19] and FET [20]. This evidence concerns the gene GNRH1 and adenomyosis.